Related by context. All words. (Click for frequent words.) 79 impaired hepatic 68 preserved systolic 67 moderate hepatic impairment 67 renal impairment 67 APTIVUS r 66 anticholinergic medications 66 moderate renal impairment 65 extrapyramidal symptoms 65 renal insufficiency 65 severe renal impairment 65 hepatic insufficiency 65 renal dysfunction 65 impaired endothelial 64 dermatologic reactions 64 left ventricular dysfunction 64 tumor lysis syndrome 64 left ventricular systolic 64 thyrotoxicosis 64 hepatic impairment 63 prolonged QT interval 63 elevated triglyceride levels 63 induce orthostatic hypotension 63 unstable angina pectoris 63 Erythropoietic therapies may 63 affective psychoses 63 SGPT 63 mild renal insufficiency 62 arterial thromboembolic events 62 proliferative diabetic retinopathy 62 hypokalemia hypomagnesemia 62 mild hepatic impairment 62 ACTOplus met XR 62 left ventricular diastolic 62 hypercholesterolaemia 62 receiving immunosuppressive therapy 62 neutropaenia 62 acarbose 62 elevated ALT 62 neutropenia thrombocytopenia 62 nephrotoxicity 62 every ERBITUX infusion 62 biliary tract disease 62 serum creatinine levels 62 INVEGA ® 62 EXJADE 62 hepatocellular 62 impaired cognition 62 aspartate aminotransferase AST 62 primary hypercholesterolemia 62 known sulfonamide allergy 62 Vaprisol 62 transaminase elevations 62 hyperkalemia 62 Pioglitazone 62 venlafaxine XR 62 acute decompensation 62 hypercalcemia 62 hyperphenylalaninemia HPA due 62 hypomagnesemia 62 ADPKD 62 serum urate levels 62 hematological parameters 62 Nilotinib 62 TMP SMX 62 severe exacerbations 62 CYP#A# substrate 61 hyperprolactinemia 61 T2DM 61 Known hypersensitivity 61 bacteriuria 61 unstable detrusor muscle 61 Lactic acidosis 61 HIV HCV coinfected 61 severe hypersensitivity reactions 61 hypokalemia 61 anticholinergics 61 HMG CoA reductase inhibitors 61 VIIBRYD 61 amisulpride 61 decompensated heart failure 61 severe renal insufficiency 61 oral antidiabetic medication 61 elevated creatinine 61 CNS depressants 61 potentially hepatotoxic 61 hypotensive 61 hepatic enzymes 61 TEAEs 61 hypophosphatemia 61 thrombocytopenia neutropenia 61 NIASPAN 61 warfarin erythromycin 61 neuroleptic 61 antiphospholipid syndrome 61 subclinical hypothyroidism 61 primidone 61 hepatic function 61 aspirin clopidogrel 61 generalized anxiety disorder GAD 61 receiving VELCADE 61 Exacerbations 61 weekly subcutaneous injections 61 abnormal clotting 61 renal toxicity 61 NPH insulin 61 VAPRISOL 61 venlafaxine Effexor 61 corticosteroid therapy 61 deep venous thromboses 61 severe neutropenia 61 multivariate adjustment 61 ACTOplus met 61 included exfoliative dermatitis 61 tolterodine ER 61 AGILECT R 61 myelodysplastic myeloproliferative diseases 61 recurrent glioblastoma multiforme 61 electrolyte abnormalities 61 smoldering multiple myeloma 61 baseline HbA1c 61 relapsed MM 61 mixed hyperlipidemia 61 clomipramine 61 receiving XGEVA 61 atrophic gastritis 60 leukopenia 60 elevated IOP 60 thrombotic events 60 Thal Dex 60 CYP #A# 60 PsA 60 concomitant medications 60 neutropenic patients 60 left ventricular hypertrophy 60 thromboembolic 60 MAO inhibitors 60 symptomatic hypotension 60 GH deficiency 60 Hashimoto thyroiditis 60 acute phosphate nephropathy 60 alpha interferons 60 myopathy rhabdomyolysis 60 metabolic acidosis 60 recurrent ischemia 60 colorectal adenoma 60 monoamine oxidase inhibitors 60 prednisone prednisolone 60 Lupus nephritis 60 thrombocytopenic 60 NUCYNTA R 60 psoriatic arthritis PsA 60 aldosterone antagonist 60 nephrotoxic 60 cirrhotic 60 paroxetine sertraline 60 olmesartan 60 nonischemic 60 thrombocytopenic patients 60 overactive bladder symptoms 60 lupus nephritis 60 Hypersensitivity reactions 60 electrolyte disturbances 60 Hypokalemia 60 nonvertebral fracture 60 amenorrhoea 60 elevated serum creatinine 60 PREZISTA r 60 hypercholesterolemic patients 60 Hypotension 60 phototoxicity 60 hepatotoxicity 60 LATUDA 60 cystic fibrosis chronic pancreatitis 60 hallucinations dyskinesia 60 benazepril 60 hypercoagulability 60 CrCl 60 INTEGRILIN R 60 calcineurin inhibitor 60 intravenous bisphosphonates 60 torsade de pointes 60 hyperalgesia 60 hsCRP levels 60 bronchial hyperresponsiveness 60 serum phosphorous 60 ACE Inhibitors 60 serum calcium levels 60 haematologic 60 hydroxymethyl coenzyme 60 FluCAM arm 60 heparin induced thrombocytopenia 60 reflux symptoms 60 troponin T 59 fatal anaphylactic 59 serum phosphate 59 microvascular disease 59 β blockers 59 anaphylactoid reactions 59 euvolemic hyponatremia 59 WARNINGS Myopathy Rhabdomyolysis 59 salmeterol fluticasone 59 antiplatelet medications 59 methimazole 59 β blocker 59 glulisine 59 lipid elevations 59 VaD 59 intracranial hemorrhage ICH 59 hyperparathyroidism 59 convulsive disorders 59 typical antipsychotics 59 morphometric vertebral fractures 59 inducible nitric oxide synthase 59 antihypertensive therapy 59 alanine aminotransferase 59 autoimmune thyroid 59 homozygous familial hypercholesterolemia 59 administered concomitantly 59 BYSTOLIC 59 angina pectoris 59 CMV infection 59 anticholinergic medication 59 aminotransferases 59 idiopathic Parkinson disease 59 hyperammonemia 59 prolactin levels 59 SIADH 59 macrovascular disease 59 prostate abnormalities 59 danazol 59 quetiapine Seroquel 59 paricalcitol 59 hypertension diabetes mellitus 59 postoperative pulmonary 59 Renal impairment 59 severe hypoglycaemia 59 thromboembolic events 59 ATACAND 59 Corticosteroids 59 familial hypercholesterolemia 59 untreated OSA 59 rFVIIa 59 hypoglycaemic episodes 59 Toxicities 59 primary aldosteronism 59 Hepatic Impairment 59 DOXIL 59 leukopenia pancytopenia thrombocytopenia 59 reflux disease 59 autonomic dysfunction 59 Myelosuppression 59 conventional DMARDs 59 inhaled bronchodilators 59 non aspirin NSAIDs 59 levodopa induced 59 amnestic mild cognitive impairment 59 potassium sparing diuretics 59 symptomatic hyponatremia 59 anthracycline taxane 59 OADs 59 leukemia AML 59 Asymptomatic 59 KETEK 59 transaminases 59 mcg kg REBETOL 59 LV dysfunction 59 systolic dysfunction 59 IBS C 59 solifenacin 59 insulin detemir 59 pancytopenia 59 conventional antipsychotics 59 TNF antagonist 59 cardiac toxicity 59 hematologic toxicity 59 sotalol 59 ULTRAM ER 59 polyp recurrence 59 gemifloxacin 59 bone marrow suppression 59 T1DM 59 systemic hypotension 59 thrombocytosis 59 constipation nausea 59 esophagitis 59 myelosuppression 59 cardiac conduction 59 certolizumab 59 aldosterone antagonists 59 stable angina 59 seropositive patients 59 pyridostigmine 59 abdominal pain headache 59 dopaminergic therapy 59 peginterferon alfa 59 Ribavirin causes 59 serum IGF 59 EFFEXOR XR 59 thyrotropin 59 adrenal suppression 59 mycophenolate 59 aMCI precursor 59 metabolic alkalosis 59 Infusion Reactions Severe 59 angiotensin II receptor blockers 59 comorbid depression 59 liver dysfunction 59 Glucocorticoids 58 hepatic failure 58 Diabetic neuropathy 58 diabetic kidney 58 endometrial hyperplasia 58 ACTEMRA TM 58 CIMZIA TM certolizumab pegol 58 levodopa therapy 58 pulmonary hypertension PH 58 renal artery stenosis 58 cytopenias 58 strong CYP#A# inducers 58 familial hypercholesterolemia FH 58 plasma folate 58 Acute Exacerbations 58 aminotransferase levels 58 malignancy HCM 58 severe hepatomegaly 58 elevated LDL cholesterol 58 Abrupt discontinuation 58 beta blocker therapy 58 decompensated liver disease 58 drug eluting stent implantation 58 INVEGA ™ 58 oral levofloxacin 58 neurologic complications 58 nicardipine 58 receiving VICTRELIS 58 Selective serotonin reuptake inhibitors 58 myocardial infarction ventricular fibrillation 58 azacitidine 58 HMG CoA reductase inhibitor 58 primary immunodeficiency PI 58 Generalized Anxiety Disorder 58 orthostatic hypotension 58 COREG 58 severe hypoglycemia 58 macrovascular complications 58 PRADAXA 58 recurrent acute pancreatitis 58 nadolol 58 thromboembolic disease 58 umol L 58 uncontrolled hypertension 58 Peripheral edema 58 coadministration 58 chronic renal insufficiency 58 erythematosus 58 abdominal adiposity 58 endotoxemia 58 Naive Patients 58 mitochondrial toxicity 58 non metastatic osteosarcoma 58 Thrombocytopenia 58 silent ischemia 58 reflux disease GERD 58 elevated triglycerides 58 nocturnal hypoglycemia 58 hemorrhagic complications 58 paresthesias 58 interstitial pneumonia 58 mitral insufficiency 58 hypervolemic hyponatremia 58 CIMZIA ™ 58 Atypical antipsychotics 58 secondary hyperparathyroidism 58 glycated hemoglobin levels 58 mcg BID 58 Chronic ITP 58 Acute Bacterial Sinusitis ABS 58 either acutely decompensated 58 severe hypoglycemic 58 ALT flares 58 oral Hycamtin 58 extrapyramidal 58 Clinically significant 58 periprocedural 58 loop diuretics 58 severe hepatic dysfunction 58 risperidone Risperdal 58 renal scarring 58 postoperative AF 58 Adalimumab 58 NUCYNTA ® 58 Comorbid 58 coagulation abnormalities 58 Tardive dyskinesia 58 dapagliflozin plus 58 lichen planus 58 antidiabetic drugs 58 nonhematologic adverse reactions 58 octreotide LAR 58 recurrent UTI 58 DULERA 58 leucopenia 58 nonalcoholic steatohepatitis NASH 58 elevated blood glucose 58 adverse cytogenetics 58 pharmacokinetic interactions 58 parkinsonism 58 Nesiritide 58 Serious adverse reactions 58 neutrophil counts 58 ICD shocks 58 unfavorable cytogenetics 58 active PsA 58 APTIVUS ritonavir 58 AA Amyloidosis 58 pentoxifylline 58 Mg Uk 58 bezafibrate 58 GI motility 58 Suicidal ideation 58 AST ALT 58 isoproterenol 58 headache abdominal pain 58 Severe Primary IGFD 58 dysfunction LVSD 58 ß blockers 58 MULTAQ 58 CsA 58 phenothiazines 58 ribavirin therapy 58 ventricular tachycardia VT 58 lymphopenia 58 tamsulosin 58 analgesic medications 58 abacavir Ziagen 58 primary generalized tonic 58 lipid lowering agents 58 desvenlafaxine succinate 58 serum potassium 58 artery stenosis 58 Tiotropium 58 mucosal inflammation 58 Hematologic 58 hypovitaminosis D 58 Patients Treated With 58 pimozide 58 C1 INH deficiency 58 torsades de pointes 58 postoperative morbidity 58 QTc prolongation 58 bacterial prostatitis 58 Thiazolidinediones 58 perioperatively 58 oral antidiabetes 58 juvenile idiopathic arthritis 58 microbleeds 58 efalizumab 58 RAS blockers 58 macroalbuminuria 58 cardiac contractility 58 citalopram Celexa 58 anaphylaxis angioedema 58 Relapsing Remitting Multiple Sclerosis 58 fasting insulin 58 hepatorenal syndrome 58 neutropenia dehydration dyspnea 58 hypocalcemia 58 cranial irradiation 58 gouty arthritis 58 anemia neutropenia 58 hypersensitivity reaction 58 postural hypotension 58 dopamine antagonists 58 acromegalic patients 58 overlapping toxicities 58 zonisamide SR 58 cardiotoxic 58 EEG abnormalities 58 MGUS 58 unresectable HCC 57 affective psychosis 57 AVELOX 57 hyperglycaemia 57 mitoxantrone plus 57 ddI 57 DMARDS 57 systemic corticosteroid 57 Neovascular AMD 57 Vitamin B# deficiency 57 aripiprazole Abilify 57 prolactin elevation 57 syncope fainting 57 DETROL LA 57 vWD 57 Primary IGFD 57 TNF blocker therapy 57 Alzheimer Disease AD 57 Aldosterone 57 pyrexia mucositis sepsis febrile 57 inhibit platelet function 57 antithyroid 57 EDARBI 57 fibrinolysis 57 oxycodone CR 57 salmeterol HFA MDI 57 tricyclic antidepressant 57 eosinophilic asthma 57 KRAS mutant tumors 57 HPA axis 57 neuropsychiatric symptoms 57 antiretroviral naive 57 radiotherapy RT 57 disordered breathing 57 hematologic adverse 57 variceal bleeding 57 Eisenmenger syndrome 57 serum folate 57 Paxil paroxetine 57 vasomotor symptoms 57 bone marrow reticulin deposition 57 asymptomatic PAD 57 cirrhotic patients 57 digoxin toxicity 57 CK MB 57 euthyroid 57 cerebrovascular accident 57 acutely decompensated congestive heart 57 BANZEL 57 Atypical Hemolytic Uremic Syndrome 57 hyperinsulinism 57 progressive dyspnea 57 receiving FUSILEV 57 elevated uric acid 57 cholecystitis 57 NYHA Class II 57 PLX STROKE targeting 57 thiazolidinedione TZD 57 BENICAR HCT 57 adrenal insufficiency 57 necrotizing pancreatitis 57 BPH benign prostatic 57 erythropoietic 57 tirofiban 57 denileukin diftitox 57 CTEPH 57 antiarrhythmic drug 57 hyperlipidaemia 57 Aortic stenosis 57 lowering blood glucose 57 syncopal 57 angiotensin converting enzyme inhibitor 57 failure ADHF 57 peritumoral brain edema 57 neuroleptics 57 pericardial effusion 57 alanine aminotransferase ALT 57 hormone receptor negative 57 thromboembolism 57 poor metabolizers 57 Cognitive Impairment 57 serum estradiol 57 parkinsonian 57 colorectal liver metastases 57 somnolence dizziness 57 generalized tonic clonic seizures 57 Tasigna prolongs 57 glomerular filtration 57 neurologic symptoms 57 Paliperidone 57 events TEAEs 57 atopic eczema 57 Subarachnoid hemorrhage 57 liver histology 57 calcium antagonists 57 anemia hemoglobin 57 serum PTH 57 neutropenic fever 57 NATRECOR ® 57 receiving prophylactic anticoagulation 57 Juvenile Idiopathic Arthritis 57 transferrin saturation 57 ARCALYST ® 57 achieved ACR# 57 QTc interval 57 idiopathic generalized epilepsy 57 Malignant Glioma 57 macular edema secondary 57 experimentally induced 57 progressive PsA 57 testicular tumors 57 creatinine clearance 57 cerebral atrophy 57 hypoglycemia unawareness 57 invasive fungal infections 57 cisplatin chemotherapy 57 tardive dyskinesia TD 57 Adverse reactions 57 Heterozygous Familial Hypercholesterolemia 57 carotid plaques 57 hypercalciuria 57 Fibrates 57 metformin sulfonylurea 57 saline placebo 57 amyloid deposition 57 cancerous colon polyps 57 hypercoagulable 57 NUCYNTA TM 57 retransplantation 57 RLAI 57 choroidal neovascularization 57 fulminant hepatitis 57 infliximab monotherapy 57 virologic failure 57 inhaled budesonide 57 serotonin reuptake 57 concomitant cardiac 57 cerebral infarction 57 PROCRIT ® 57 NATRECOR R 57 Renal Impairment 57 delayed CINV 57 giant cell arteritis 57 LHRH agonists 57 insulin secretagogue 57 neurotrophic 57 tipranavir r 57 lactate dehydrogenase LDH 57 ventricular tachyarrhythmia 57 microangiopathy 57 detrusor overactivity 57 systemic corticosteroids 57 tricyclic antidepressants 57 Chemotherapy induced 57 tamoxifen Nolvadex ® 57 liver transaminases 57 Hypoglycemia 57 lactase deficiency 57 anticholinergic agents 57 Peginterferon 57 serum sodium 57 lispro 57 angiotensin converting enzyme inhibitors 57 lopinavir r arm 57 peripheral sensory neuropathy 57 angina chest 57 liver metastasis 57 extrapyramidal symptoms EPS 57 basiliximab 57 adjunctive placebo 57 Myocardial infarction 57 advanced adenoma 57 mcg QD 57 generalized edema 57 bronchopulmonary dysplasia 57 acute myocardial infarction AMI 57 thyroxine 57 metastatic carcinoid tumors 57 gastrointestinal GI motility disorders 57 ARIXTRA 57 coinfected patients 57 hypoglycemic episodes 57 containing abacavir 57 overactive bladder syndrome 57 titrated glipizide 57 omeprazole Prilosec 57 comorbid anxiety 57 Pharmacokinetics PK 57 NOLVADEX 57 Relapsed Multiple Myeloma 57 LOVENOX R 57 serum urate 57 Dementia Related Psychosis 57 carbamazepine Tegretol 57 REYATAZ r arm 57 onset diabetes mellitus 57 sulphonylureas 57 thromboembolic complications 57 gout flare 57 sympathomimetic amines 57 Starlix 57 untreated celiac disease 57 valvular disease 57 angiotensin converting enzyme ACE 57 CANCIDAS 57 recurrent atrial fibrillation 57 carotid artery blockage 57 systolic hypertension 57 headache nausea fatigue 57 euthymic 57 lamotrigine 57 atrial tachyarrhythmias 57 SUSTENNA TM 57 ocular adverse 57 pyelonephritis 57 intracranial atherosclerosis 57 ejection fractions 57 cardiac dysfunction 57 HeFH 57 lactic acidosis 57 atherothrombotic 56 ecchymosis 56 blood Phe levels 56 ursodeoxycholic acid 56 inhaled glucocorticoids 56 metastatic malignant 56 serum calcium 56 NOMID 56 PROCRIT 56 COPD exacerbation 56 tremor slowness 56 chronic metabolic acidosis 56 capillary leak 56 hypersomnia 56 Topiramate 56 Coumadin warfarin 56 cabergoline 56 substantially excreted 56 thrombotic 56 Relapsed Refractory 56 immunosuppressive regimen 56 fluid overload 56 normotensive 56 unresectable tumors 56 ritonavir boosted 56 euthymic patients 56 ropivacaine 56 abacavir lamivudine 56 idraparinux 56 emotional lability 56 metformin accumulation 56 isolated systolic hypertension 56 sustained ventricular tachycardia 56 postoperative delirium 56 juvenile myoclonic epilepsy 56 impair cognitive 56 ULORIC 56 oral hypoglycemic agents 56 hyperreflexia 56 aortic valve stenosis 56 patients undergoing CABG 56 triiodothyronine 56 SJIA 56 dysglycemia 56 COPEGUS therapy 56 baseline serum creatinine 56 immunosuppressed 56 ziconotide 56 heterozygous FH 56 adriamycin 56 immunosuppressive agents 56 liver decompensation 56 NMIBC 56 valsartan amlodipine 56 sulphonylurea 56 diabetic gastroparesis 56 perimenopausal women 56 mIU L 56 intermittent claudication 56 amitriptyline Elavil 56 nausea dizziness vomiting 56 virological failure 56 basal cell nevus syndrome 56 coadministered 56 postoperative complication 56 treatment emergent adverse 56 choroidal vasculopathy 56 gastrointestinal disturbances 56 TORISEL 56 serum aminotransferase levels 56 nondiabetic patients 56 C Reactive Protein 56 AAT deficiency 56 haloperidol Haldol 56 plus methotrexate 56 Primary Hypercholesterolemia 56 adrenal function 56 paroxysmal AF 56 vasospasm 56 Fuchs dystrophy 56 thyroid hormone replacement 56 haemolysis 56 Antitumor Activity 56 somnolence fatigue 56 Severe Sepsis 56 maximally tolerated lipid lowering 56 cerebral vasospasm 56 4mg/kg 56 akinesia 56 carotid stenosis 56 Subgroup analyzes 56 protein excretion 56 urinary N telopeptide 56 hepatic fibrosis 56 antiarrhythmic drugs 56 Platinol ® 56 hypovolemic 56 noncardiovascular mortality 56 subtrochanteric 56 headache nasopharyngitis 56 oral hypoglycemic agent 56 serum lipid levels 56 chronic myeloid 56 anticholinergic effects 56 Glioblastoma Multiforme GBM 56 pancreatic insufficiency 56 microvascular complications 56 dermopathy 56 Mitomycin C 56 apolipoprotein E4 56 Heart Failure Patients 56 CP CPPS 56 juvenile idiopathic arthritis JIA 56 hepatic enzyme 56 transaminase levels 56 hypercholesterolemia 56 Valproate 56 mucocutaneous reactions 56 Hepatotoxicity 56 PRISTIQ 56 Calcium intake 56 Chronic Constipation 56 glycosylated hemoglobin HbA1c 56 posttransplant 56 imatinib resistance 56 mCRC acneform rash 56 INVANZ 56 serum cortisol 56 β cell 56 premenstrual syndrome PMS 56 CYP#C# [001] 56 oral olanzapine 56 biphasic insulin aspart 56 SSc 56 Parnate 56 mania hypomania 56 Nebulized 56 hypotension 56 anticoagulants blood thinners 56 hypertensives 56 Stent thrombosis 56 angioneurotic edema 56 pretransplant 56 terazosin 56 Proteinuria 56 flutamide 56 myelosuppressive 56 Atherosclerotic 56 ACEIs 56 partial onset seizures 56 L dopa 56 breast endometrial 56 Candesartan 56 lactate dehydrogenase 56 nephrotoxic drugs 56 infective endocarditis 56 akathisia 56 Microalbuminuria 56 bronchospasm 56 Ileus 56 hyperglycemia 56 glycated hemoglobin HbA1c 56 ANCA associated 56 elevated fasting glucose 56 riociguat 56 atherothrombosis 56 serologically active systemic lupus 56 AZILECT 56 narrowed carotid arteries 56 postoperative atrial fibrillation 56 eplerenone 56 autoantibody levels 56 intracerebral 56 renal allograft 56 poststroke 56 hypoperfusion 56 Sodium oxybate 56 stage IIIb IV 56 confusional 56 SGOT 56 fluticasone salmeterol 56 CHD CVD 56 premorbid 56 overt nephropathy 56 benign prostate 56 dalteparin 56 Tasimelteon 56 renovascular hypertension 56 discontinuations due 56 hepatic dysfunction 56 neovascular 56 NMDA antagonists 56 hemorrhagic cystitis 56 SHPT 56 venous thrombosis 56 underactive thyroid gland 56 Patients Receiving 56 nephropathy 56 anticoagulant medications 56 enalapril 56 NNT = 56 nonadherence 56 PSA nadir 56 polycystic ovary syndrome PCOS 56 canakinumab 56 postural instability 56 serotonergic drugs 56 esophageal gastric 56 anakinra 56 lupus erythematosus 56 dyslipidaemia 56 Anticoagulants 56 cytopenia 56 Angiotensin receptor blockers 56 severely active polyarticular 56 ventricular fibrillation VF 56 intravascular hemolysis 56 chronic immune thrombocytopenic 56 akinetic mutism 56 heterotaxy 56 drotrecogin alfa activated 56 H2 receptor antagonists 56 androgen deficiency 56 bladder carcinoma 56 dysthymic 56 euvolemic 56 serum potassium levels 56 albumin excretion rate 56 pulmonary exacerbation 56 Acetaminophen Tylenol 56 corticosteroid dose 56 NOXAFIL 56 generalized epilepsy 56 nausea vomiting headache 56 refractory gout 56 onset seizures 56 AVODART 56 vasodilators 56 idiopathic PAH 56 verapamil 56 Hp2 2 56 diabetes mellitus DM 56 PegIFN RBV 56 advanced adenomas 56 atopic 56 Glimepiride 56 Hypertensive 56 Quetiapine 56 bladder dysfunction 56 haemorrhagic stroke 56 CTAP# 56 opioid dependent 56 fat malabsorption 56 deletion 5q 56 Oral Fingolimod 56 intracranial hypertension 56 methicillin susceptible Staphylococcus aureus 56 minimally symptomatic 56 Mild hypothermia 56 alteplase 56 OAB symptoms 56 albuminuria 56 inotropic 56 Sjögren syndrome 56 recurrent VTE 56 myalgia arthralgia 56 indomethacin 56 recurrent genital herpes 56 neuropsychological deficits 56 airway hyperresponsiveness 56 leptin deficiency 56 serotonin norepinephrine 56 gallstone disease 56 neurocognitive deficits 56 paroxetine Paxil 56 occlusive disease 56 chronic GVHD 56 dobutamine 56 symptomatic intracranial 56 HNSCC 56 reactogenicity 56 Index CDAI 56 Ventricular Tachycardia 56 immune thrombocytopenic purpura 56 APOE e4 56 sensory neuropathy 56 proliferative retinopathy 56 COPD exacerbations 56 apneic episodes 56 urate lowering 56 JANUMET 56 induce remission 56 lung metastasis 56 chemotherapy induced neutropenia 56 chronic idiopathic thrombocytopenic purpura 55 Hyperkalemia 55 oral corticosteroid 55 mild renal impairment 55 autoimmune reactions 55 IL 1ß